Haemonetics | HAE - Sales Revenues


Haemonetics reported $346M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Avanos Medical USD 182.2M 1.3M Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Cerus USD 50.81M 4.79M Dec/2024
Cooper Companies USD 1.08B 57.4M Mar/2026
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
Globus Medical USD 759.85M 66.55M Mar/2026
Haemonetics USD 346M 7.03M Mar/2026
ICU Medical USD 525.77M 14.93M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
Masimo USD 403.6M 8.9M Mar/2026
Medtronic USD 9.8B 800M Mar/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Quidel USD 620M 104M Mar/2026
ResMed USD 1.4B 0 Mar/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Steris USD 1.59B 90M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Surmodics USD 29.57M 355K Jun/2025
Teleflex USD 548.3M 20.68M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
US Physical Therapy USD 198.3M 4.43M Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026